Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of non-adjuvanted inactivated influenza A(H1N1) vaccine in renal transplant recipients
2009-016659-23Phase 2Completed
- Sponsor
- Inserm
- Start
- Nov 2009
- Countries
- 1
01
Overview
Phase 2, single-arm trial of inactivated non-adjuvanted pandemic H1N1 vaccine in Influenza A infection, sponsored by Inserm. Primary endpoints: Humoral immunogenicity after first dose and Humoral immunogenicity after second dose. Started Nov 2009; status: completed.
02
Drugs
inactivated non-adjuvanted pandemic H1N1 vaccine
03
Conditions
Influenza A infection
Beyond the preview
Go deeper on 2009-016659-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016659-23.